MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Potential Disease-Modifying Effects in Mild Parkinson’s Disease following High Intensity Aerobic Exercise: a Case Report

    L. Goh, N. Allen, G. Angelis, S. Meikle, N. Johnson, J. Lv, C. Sue, S. Paul (Camperdown, Australia)

  • Precision Functional MRI Mapping of Therapeutic Response in Focal Hand Dystonia

    A. Morris, L. Xavier, A. Meyer, E. Gordon, S. Norris (Saint Louis, USA)

  • Precision Gene Therapy Results in Clinical Benefit and Developmental Gains for Aromatic L-Amino Acid Decarboxylase Deficiency (AADCd): The UK Experience

    A. Salazar-Villacorta, R. Spaull, L. Carr, J. Hassell, S. Pope, S. Heales, R. Shihurkar, K. Bankiewicz, T. Pearson, K. Aquilina, M. Kurian (London, United Kingdom)

  • Precision Management of Oromandibular Dystonia (OMD): The Role of Neurological examination, Electromyographic (EMG) Guidance, and Odontological evaluation (OE) – A descriptive study with a Multidisciplinary Approach for Botulinum Toxin A (BoNT/A) Treatment

    A. Stark, H. Biernat, K. Benedek, P. Mcgettigan, M. Bakke, A. Lokkegaard (Rsokilde, Denmark)

  • Predicting Long Term Outcome of Gait Kinematics with Chronic Deep Brain Stimulation in Patients with Parkinson’s Disease

    J. Al Ali, S. Miocinovic, L. Mckay, J. Nocera, F. Isbaine, J. Tran, P. Testini, S. Triche, C. Esper, P. Aia, L. Scorr, L. Higginbotham, R. Tripathi, N. Au Yong, C. Buetefisch (Atlanta, USA)

  • Predicting Parkinson’s Disease Motor Progression Using Clinical and Digital Data

    T. Aubourg, K. Gunter, C. Lo, J. Welch, K. Groenewald, J. Klein, J. Razzaque, L. van Hillegondsberg, PL. Ratti, A. Nastasa, G. Auld, R. Mccomish, A. King, K. Chowdhury, N. Vijiaratnam, C. Girges, T. Foltynie, S. Arora, M. Hu (Sheffield, United Kingdom)

  • Predicting Parkinson’s disease severity and cognitive decline using blood-based ferroptotic biomarkers

    V. Huin, E. Cailliau, G. Garçon, M. Dutheil, O. Simonin, N. Beauval, J. Labreuche, D. Blum, C. Moreau, E. Hainque, A. Marques, A. Eusebio, I. Benatru, C. Brefel-Courbon, D. Maltete, C. Giordana, M. Tir, S. Thobois, JP. Brandel, B. Jarraya, L. Hopes, O. Rascol, JC. Corvol, D. Devos, AS. Rolland (Lille, France)

  • Predicting the Cognitive-Psychiatric Phenotype of Parkinson’s Disease

    H. Dhanis, J. Potheegadoo, S. Stampacchia, F. Bernasconi, C. Stucker, M. Maradan, L. Thanh, L. Jenni, J-A. Ghika, P. Burkhard, B. Vicki, D. Benninger, J. Horvath, P. Krack, D. de Ville, O. Blanke (Bern, Switzerland)

  • Predictive clinical factors for the faster progression from idiopathic late-onset cerebellar ataxia to multiple system atrophy cerebellar type

    SM. Lee, HJ. Kim, JH. Shin (Seoul, Republic of Korea)

  • Predictor of post-deep brain stimulation cognitive decline in Parkinson’s disease patients

    L. Montaser-Kouhsari, E. Narinsky, M. Fox (Boston, USA)

  • « Previous Page
  • 1
  • …
  • 128
  • 129
  • 130
  • 131
  • 132
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley